Published in J Clin Pathol on June 01, 2000
A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer (1975) 10.04
Formation and detection of RNA-DNA hybrid molecules in cytological preparations. Proc Natl Acad Sci U S A (1969) 5.56
Improvement in the staining and in the visualization of the argyrophilic proteins of the nucleolar organizer region at the optical level. Histochem J (1986) 5.31
Biological activities of immunoglobulins of different classes and subclasses. Adv Immunol (1974) 5.22
Nucleolar organizer regions in lymphomas. J Pathol (1987) 4.46
Plasma cell labeling index and beta 2-microglobulin predict survival independent of thymidine kinase and C-reactive protein in multiple myeloma. Blood (1993) 2.98
How should we count AgNORS? Proposals for a standardized approach. J Pathol (1989) 2.35
Proliferation markers in tumours: interpretation and clinical value. J Clin Pathol (1998) 1.62
Histologic classification and staging of multiple myeloma. A retrospective and prospective study of 674 cases. Am J Clin Pathol (1987) 1.56
Why better prognostic factors for multiple myeloma are needed. Blood (1994) 1.44
The nucleolus and the nucleolar organizer regions. Biol Cell (1986) 1.20
Immunoglobulin synthesis and tumor kinetics of multiple myeloma. Semin Hematol (1973) 1.17
Nucleolar organiser regions in pathology. Br J Cancer (1992) 1.12
Nucleolar organizer regions as diagnostic discriminants for malignancy. J Pathol (1988) 1.05
Clinical, morphological, and cell kinetic differences among multiple myeloma, monoclonal gammopathy of undetermined significance, and smoldering multiple myeloma. Blood (1983) 1.04
Importance of interphase nucleolar organizer regions in tumor pathology. Virchows Arch B Cell Pathol Incl Mol Pathol (1991) 0.93
Risk groups of myeloma patients by histologic pattern and proliferative activity. Am J Surg Pathol (1997) 0.87
Nucleolar organizer region counts predict complete remission, remission duration, and survival in adult acute myelogenous leukemia patients. J Clin Oncol (1998) 0.82
Relationship between morphometric analysis of nucleolar organizer regions and cell proliferation in acute leukemias. Cytometry (1998) 0.80
Prognostic implications of proliferating cell nuclear antigen (PCNA), AgNORs and P53 in non-Hodgkin's lymphomas. Leuk Lymphoma (1998) 0.80
Argyrophilic nucleolar organizer region counts and prognosis in multiple myeloma. Br J Haematol (1992) 0.80
Expression of proliferating cell nuclear antigen (PCNA) and nucleolar organizer regions (NORs) in multiple myeloma. Anticancer Res (1994) 0.80
Nucleoli and AgNORs in Hodgkin's disease. Mol Pathol (1997) 0.79
Therapy for multiple myeloma with alternating non-cross-resistant chemotherapy combinations: heterogeneity of tumor responsiveness. Cancer Treat Rep (1984) 0.78
Correlation between argyrophilic nucleolar organizer region counts and labelling index in multiple myeloma. Eur J Haematol (1996) 0.78
Nucleolar organizer regions in exocrine pancreas in chronic pancreatitis and ductal adenocarcinoma. Diagnostic value and cytophysiologic correlate. Gen Diagn Pathol (1997) 0.78
Nucleolar organiser regions in myeloma and benign paraproteinaemia. Br J Cancer (1990) 0.77
Rituximab monotherapy is highly effective in splenic marginal zone lymphoma. Hematol Oncol (2007) 1.75
Cytologically interesting cases of primary skin tumors and tumor-like conditions identified by fine-needle aspiration biopsy. Diagn Cytopathol (1998) 1.14
Long acting octreotide in the treatment of advanced hepatocellular cancer and overexpression of somatostatin receptors: randomized placebo-controlled trial. World J Gastroenterol (2007) 1.03
Fine-needle aspiration cytology in tumors and tumor-like conditions of the oral and maxillofacial region: diagnostic reliability and limitations. Cancer (1997) 1.01
The role of fine needle aspiration cytology in the diagnosis of primary skin tumors. Arch Anat Cytol Pathol (1993) 1.00
Soluble interleukin-6 receptor (sIL-6R), a new prognostic factor in multiple myeloma. Br J Haematol (1996) 0.95
Serum transforming growth factor-beta 1 is related to the degree of immunoparesis in patients with multiple myeloma. Med Oncol (1998) 0.91
Fine needle aspiration (FNA) biopsy of primary cutaneous meningioma: report of two cases. Cytopathology (1999) 0.83
Multiple myeloma as the first manifestation of acquired immunodeficiency syndrome: a case report and review of the literature. Ann Hematol (2001) 0.83
Chemotherapy-related acute rhabdomyolysis. J Natl Cancer Inst (1992) 0.83
Pre-operative evaluation of parotid tumours by fine needle biopsy. Eur J Surg Oncol (1998) 0.80
Recurrence of acute leukemia in donor cells after bone marrow transplantation: documentation by in situ DNA hybridization. Bone Marrow Transplant (1993) 0.79
The diagnostic value of fine needle aspiration cytology in Waldeyer's ring lymphomas. Oral Oncol (2001) 0.78
Axonal sensorimotor neuropathy in patients with beta-thalassaemia. J Neurol Neurosurg Psychiatry (2004) 0.78
Serum interleukin-6 (IL-6) and interleukin-4 (IL-4) in patients with multiple myeloma (MM). Br J Haematol (1996) 0.78
Fine needle aspiration of adrenal myelolipoma: a case report. Cytopathology (1992) 0.77
Predictive factors affecting mobilization and peripheral blood stem cell (PBSC) collection using single apheresis (SA) for rescuing patients after high-dose chemotherapy (HD.CHE) in various malignancies. Bone Marrow Transplant (1996) 0.77
Systolic and diastolic function in middle aged patients with sickle beta thalassaemia. An echocardiographic study. Postgrad Med J (2005) 0.75
An unusual cytogenetic abnormality involving chromosomes 1 and 7 in a case of chronic myelomonocytic leukemia. Cancer Genet Cytogenet (1995) 0.75
Sources of discrepancies in the diagnosis of Hodgkin's disease by fine needle aspiration. Arch Anat Cytol Pathol (1996) 0.75
Rapid cytological diagnosis of primary skin tumours and tumour-like conditions. Acta Derm Venereol (1997) 0.75
A new look in the management of unresectable primary hepatocellular carcinoma. Hepatogastroenterology (1992) 0.75
Factors influencing distant tele-evaluation in cytology, pathology, conventional radiology and mammography. Anal Cell Pathol (1996) 0.75
beta(2)-microglobulin in Hodgkin's lymphoma: prognostic significance in patients treated with ABVD or equivalent regimens. J BUON (2007) 0.75
Aspiration biopsy (FNA) in patients with various lung lesions. In Vivo (1996) 0.75
Sarcomatoid differentiation of renal cell carcinoma: a clinical case with literature review. J BUON (2008) 0.75
The role of cytology in the diagnosis of benign and malignant anal lesions. Acta Chir Iugosl (2006) 0.75
Real-time ultrasound-guided fine needle cytology of the thyroid gland by capillary action. A modified technique without aspiration. J BUON (2011) 0.75
Intermediate dose of intravenous melphalan in advanced multiple myeloma. Oncology (1991) 0.75